June 11, 2021
MEBO Provided Assistance to Alleviate the Epidemic In India
In March 2021, Covid-19 broke out in India again, which caused extensive worry around the world. The number of new cases in a single day in India exceeded 400,000. According to the World Health Organization, this accounted for more than 25% of the daily reported cases worldwide. The newly reported cases in five states account for nearly 55% of the total in the whole India. The sudden outbreak of the epidemic severely damaged the entire medical system in India. Hospitals were overcrowded with patients and suffered severe shortage of supplies.
After learning about the situation in India, MEBO Group immediately established an emergency team and adopted emergency measures. It contacted medical material suppliers at home and abroad to assist Indian medical institutions in fighting the epidemic.
The emergency team learned about the situation from the cooperative medical institutions in Indiaand then developed detailed donation plan, donating more than 300,000 rupees of various medical suppliesto medical institutions that had maintained long-term cooperation with MEBO Group, including N95 masks,PPE, shoe covers, surgical caps, medical gloves and disinfectant products.
After receiving the supplies, Dr. Renu Mahindru, the head of Mahindru Hospital, said: "Thanks MEBO Pharmaceutical (India) Private Limited Company for their generous assistance. The donated medical supplies helpedus a lot in the treatment of patients. They are really urgently needed" 。
About MEBO Pharmaceuticals (India) Private Limited Company：
MEBO Pharmaceuticals (India) Private Limited Companywasestablished by MEBO Group in 2010. Since its establishment in India, it had maintained close cooperation with government hospitals and private hospitals and clinics in India to promote regenerative medicine technology in the Indian market. In the past ten years, MEBO products had been highly recognized by local hospitals and clinics andremarkable results had been achieved in the treatment of burn patients. MEBO Group aims to provide patients with the best treatment for various skin injuries resorting to its world-class regenerative medical technology.
MEBO Pharmaceuticals (India) Private Limited Company has a long-term commitment in the treatment of burns and chronic wounds and has made heavy investments to serve Indian patients. Up to now, MEBO has established long-term cooperative relationships with more than 50 medical institutions and provided drug services to more than 40 independent pharmacies in the Indian market.
As early as in 2018, MEBO Group established close academic ties with many local medical institutions in India. The second wave of Covid-19 in India became the concerns of all employees of MEBO Group. In spite of severe shortage of medical materials, MEBO Group entrusted MEBO Pharmaceuticals (India) Private Limited Companyto deliver medical supplies with the MEBO logo to the hands of Indian medical staff during fight against the epidemic.
Contributed by International Department
June 11, 2021